Adcentrx Therapeutics Logo
  • About
    • Our Mission
    • Management Team
  • Our Science
    • Adcentrx Toolbox
    • Pipeline
  • News
  • Careers
  • Contact

Adcentrx Therapeutics Announces FDA Clearance of Investigational New Drug Application for ADRX-0706, a Novel ADC Targeting Nectin-4 for the Treatment of Advanced Solid Tumors

Adcentrx Therapeutics Announces Completion of $38 million Series A+ Financing Led by Eight Roads Ventures

5580 Morehouse Dr, Suite 210, San Diego, CA 92121
info@adcentrx.com
  • About
  • Our Science
  • News
  • Careers
  • Contact

Terms of Use  |  Privacy Policy

© 2022 Adcentrx Therapeutics. All Rights Reserved.